263 related articles for article (PubMed ID: 35234272)
21. A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients.
Yao Q; Wang P; Wang X; Qie G; Meng M; Tong X; Bai X; Ding M; Liu W; Liu K; Chu Y
Pol Arch Intern Med; 2020 May; 130(5):390-399. PubMed ID: 32329978
[TBL] [Abstract][Full Text] [Related]
22. SARS‑CoV‑2 spike protein‑induced host inflammatory response signature in human corneal epithelial cells.
Zhu G; Lyu L; Yang H; Liu G; Yang S; Gu C; Wang L; Yan H; Hu M; Che C
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132373
[TBL] [Abstract][Full Text] [Related]
23. Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19.
Schoeman D; Fielding BC
mSphere; 2021 May; 6(3):. PubMed ID: 33980671
[TBL] [Abstract][Full Text] [Related]
24. Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review).
Turrubiates-Hernández FJ; Sánchez-Zuno GA; González-Estevez G; Hernández-Bello J; Macedo-Ojeda G; Muñoz-Valle JF
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33537824
[TBL] [Abstract][Full Text] [Related]
25. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review).
Skalny AV; Rink L; Ajsuvakova OP; Aschner M; Gritsenko VA; Alekseenko SI; Svistunov AA; Petrakis D; Spandidos DA; Aaseth J; Tsatsakis A; Tinkov AA
Int J Mol Med; 2020 Jul; 46(1):17-26. PubMed ID: 32319538
[TBL] [Abstract][Full Text] [Related]
26. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
27. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
28. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.
Tanwar V; Adelstein JM; Wold LE
Cardiovasc Res; 2021 Jan; 117(1):85-95. PubMed ID: 33084879
[TBL] [Abstract][Full Text] [Related]
29. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Edmonston DL; South AM; Sparks MA; Cohen JB
Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
[TBL] [Abstract][Full Text] [Related]
30. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M
J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317
[TBL] [Abstract][Full Text] [Related]
31. Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).
Cavalli E; Bramanti A; Ciurleo R; Tchorbanov AI; Giordano A; Fagone P; Belizna C; Bramanti P; Shoenfeld Y; Nicoletti F
Int J Mol Med; 2020 Sep; 46(3):903-912. PubMed ID: 32588061
[TBL] [Abstract][Full Text] [Related]
32. SARS-Cov-2: Biology, Detection, Macrophage Mediated Pathogenesis and Potential Treatments.
Borges-Velez G; Rosario-Rodriguez LJ; Rosado-Philippi JE; Cartagena LJ; Garcia-Requena L; Gonzalez A; Perez J; Melendez LM
Virol Immunol J; 2020; 4(2):. PubMed ID: 34485853
[TBL] [Abstract][Full Text] [Related]
33. COVID-19: Significance of antibodies.
Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
[TBL] [Abstract][Full Text] [Related]
34. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
35. Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?
Lewandowski K; Rosołowski M; Kaniewska M; Kucha P; Meler A; Wierzba W; Rydzewska G
Pol Arch Intern Med; 2021 Feb; 131(2):121-127. PubMed ID: 33314875
[TBL] [Abstract][Full Text] [Related]
36. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
Łodyga M; Maciejewska K; Eder P; Waszak K; Stawczyk-Eder K; Michalak M; Dobrowolska A; Wiśniewska-Jarosińska M; Gąsiorowska A; Cicha M; Wierzba W; Rydzewska G
Pol Arch Intern Med; 2021 Mar; 131(3):226-232. PubMed ID: 33544564
[TBL] [Abstract][Full Text] [Related]
38. Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Gnavi R; Demaria M; Picariello R; Dalmasso M; Ricceri F; Costa G
Clin Infect Dis; 2020 Nov; 71(16):2291-2293. PubMed ID: 32442294
[TBL] [Abstract][Full Text] [Related]
39. Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection.
Georgakopoulou VE; Makrodimitri S; Triantafyllou M; Samara S; Voutsinas PM; Anastasopoulou A; Papageorgiou CV; Spandidos DA; Gkoufa A; Papalexis P; Xenou E; Chelidonis G; Sklapani P; Trakas N; Sipsas NV
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35551416
[TBL] [Abstract][Full Text] [Related]
40. Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report.
Zhang X; Chen J; Sun J; Gao S; Zhao F; Qian N
Oncol Lett; 2024 Apr; 27(4):169. PubMed ID: 38455664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
